dr mary claire haver and glp 1 Haver, MD Dr Mary Claire Haver -

Osteoporos Int (2007) 18(4):42744.10.1007/s00198-006-0253-4 2 SeinoYKanekoSFukudaSOsonoiTShiraiwaTNishijimaKet alCombination therapy with liraglutide and insulin in Japanese patients with type 2 diabetes: a 36-week, randomized, double-blind, parallel-group trial

[DOI] [PMC free article] [PubMed] [Google Scholar] 771.Carraro-Lacroix L.R., Malnic G., Girardi A.C

Subsequently, Moore proposed the hypothesis that intestinal secretions might have a glycemic-lowering effect in diabetics, which was the first study to suggest an effect of intestinal secretions on blood glucose (Perley and Kipnis, 1967)

The findings are relevant for long Covid, which shares many symptoms with MCAS

T1R3 knockout mice exhibit impaired GLP-1 secretion and glucose intolerance (130)